FDA Webview
X
about-us-banner

FDA Related News

Home / Articles / FDA Related News
Human Drugs

Shire Seeks Approval for Flexbumin Manufacturing Facility

Shire files a submission seeking FDA approval for a new plasma manufacturing operation near Covington, GA to manufacture Flexbumin 25% [albumin (human...

Federal Register

Regulatory Review Period Determined for Taltz

Federal Register notice: FDA determines for patent extension-related purposes the regulatory review period for Eli Lillys Taltz (ixekizumab).

Human Drugs

Provide Reviews with CRLs: Attorneys

Three Hyman, Phelps attorneys argue that CDER should change its current process and permit applicants who receive a complete response letter to also h...

Human Drugs

Biopharmaceutical Classification Biowaivers Guidance

FDA publishes a draft ICH guidance on biopharmaceutics classification system-based biowaivers.

Federal Register

Drug Development Testicular Toxicity Guide

Federal Register notice: FDA makes available a guidance entitled Testicular Toxicity: Evaluation During Drug Development.

Federal Register

Draft Guide on Drug Supplier Verification Systems

Federal Register notice: FDA makes available a draft guidance entitled Verification Systems Under the Drug Supply Chain Security Act for Certain Presc...

Human Drugs

FDA Gets New Opioid Fight Authorities

FDA commissioner Scott Gottlieb says the agency gained new authorities under the SUPPORT bill to combat the nations opioid crisis.

Medical Devices

CDRH Posts ASCA Information

CDRH posts information about its planned Accreditation Scheme for Conformity Assessment pilot program to accredit testing laboratories.

Medical Devices

Revised Safety Alert on Alcons CyPass Micro-Stent

FDA issues a revised safety alert on Alcons CyPass Micro-Stent due to its risk of eye damage.

Human Drugs

Masimo RD SET for Pulse Oximetry Cleared

FDA clears a Masimo 510(k) for the RD SET sensors with Masimo Measure-through Motion and Low Perfusion SET pulse oximetry that is intended to provide ...